➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Express Scripts
Baxter
McKesson
Johnson and Johnson

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Furosemide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for furosemide and what is the scope of freedom to operate?

Furosemide is the generic ingredient in two branded drugs marketed by Abraxis Pharm, Accord Hlthcare, Am Regent, Amneal Pharms Co, Astrazeneca, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Sanofi Aventis Us, Hikma, Wockhardt Bio Ag, Ani Pharms Inc, Avet, Dava Pharms Inc, Ipca Labs Ltd, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs Teva, and Us Pharm Holdings, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for furosemide. Forty-six suppliers are listed for this compound.

Drug Prices for furosemide

See drug prices for furosemide

Drug Sales Revenue Trends for furosemide

See drug sales revenues for furosemide

Recent Clinical Trials for furosemide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wright State UniversityPhase 4
Otsuka Pharmaceutical VietnamN/A
Gia Dinh People HospitalN/A

See all furosemide clinical trials

Pharmacology for furosemide
Medical Subject Heading (MeSH) Categories for furosemide

US Patents and Regulatory Information for furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leading Pharma Llc FUROSEMIDE furosemide TABLET;ORAL 077293-002 Nov 9, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Avet FUROSEMIDE furosemide TABLET;ORAL 018413-001 Nov 30, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Ipca Labs Ltd FUROSEMIDE furosemide TABLET;ORAL 078010-002 Sep 18, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us LASIX furosemide INJECTABLE;INJECTION 016363-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sanofi Aventis Us LASIX furosemide SOLUTION;ORAL 017688-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
Boehringer Ingelheim
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.